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Capsaicin, the active component of chili peppers, is an alkaloid that causes tissue irritation and 
burning especially upon contact with mucous membranes. While favored in certain cuisines around 
the world, it has also been weaponized in the form of pepper sprays and bear repellents. When 
significant capsaicin exposures occur, patients may present to the emergency department; thus, 
providers should be prepared to manage these cases effectively. In this case report we discuss an 
unusual exposure of capsaicin to the vaginal mucosa with successful treatment. [Clin Pract Cases 
Emerg Med. 2019;3(3):219-221.]
INTRODUCTION
In 2017 the American Association of Poison Control 
Centers reported 2,229 exposures to capsicum-containing 
peppers, 215 of which were treated in a healthcare facility. An 
additional 3,320 exposures to capsicum defense sprays were 
reported, and 833 of these sought medical care.1 Pepper sprays 
are prevalent and commercially available in the United States. 
They contain the active ingredient oleoresin capsicum, which 
is an oily extract composed primarily of capsaicinoids. These 
hydrophobic, fat-soluble phenols are produced by chili 
peppers and elicit significant pain and burning upon tissue and 
mucous-membrane exposure.2 Capsaicinoids act as a direct 
irritant, in addition to causing secondary neurogenic 
inflammation elicited by capsaicin’s (Figure) interaction with 
sensory neurons via the vanillin receptor subtype 1 (TRPV).3 
The hydrophobic nature of these compounds explains why 
water and other hydrophilic solvents are minimally effective 
in alleviating their noxious effects.4 
While oral mucosal exposures to capsaicin are fairly 
common, other body areas can be affected in situations such 
as military training, police actions, and self-defense where 
non-lethal means of subduing individuals is required. Effects 
vary based on the anatomic site involved. Dermatological 
exposures induce burning, hyperalgesia and erythema. 
Ophthalmic effects include blepharospasm, conjunctivitis, 
corneal erosions, and periorbital edema, whereas inhalation 
often results in dyspnea and a burning sensation in the chest.5,6 
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Figure. Capsaicin molecular structure, C18H27NO3.
C, carbon, H; hydrogen; N, nitrogen; O, oxygen.
Various strategies for neutralizing the pain and burning of 
capsaicin exposure have been explored including baby shampoo, 
mixtures of detergent solutions, milk, topical anesthetics, and 
antacid solutions such as calcium carbonate.7 Specialized 
decontaminants such as Sudecon wipes have been developed, as 
well as SABRE Decon and BioShield sprays commonly used by 
law enforcement. These methods use detergents, surfactants, or 
other hydrophobic molecules with the ability to displace and 
neutralize the compound. The following case report describes an 
unusual capsaicin exposure and subsequent effective treatment in 
the emergency department (ED).
CASE REPORT
A 22-year-old female presented to the ED with the chief 
complaint of severe vaginal pain and burning. The patient 
reported that she was a security guard who routinely carried 
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What do we already know about this clinical 
entity? 
Capsaicin is a hydrophobic, fat-soluble 
compound that acts as a direct irritant to 
mucosal surfaces, causing significant pain 
and burning upon exposure.
What makes this presentation of disease 
reportable? 
This is an unusual exposure of capsaicin 
to the vaginal mucosa with a unique and 
effective means of management.
What is the major learning point? 
Capsaicinoids are best displaced by 
hydrophobic solutes. Furthermore, topical 
anesthetics such as lidocaine are effective in 
temporarily alleviating pain via inhibition of 
sensory neurons. 
How might this improve emergency 
medicine practice? 
This report adds to the emergency physician’s 
toolbox by providing a quick and effective 
means of managing an exposure to capsaicin 
with frequently available products.
pepper spray in her bag. She was not aware that the canister 
had discharged into the bag containing personal items 
including tampons. When the patient subsequently inserted the 
tampon she immediately experienced severe vaginal mucosal 
burning that was not relieved after removal of the tampon; so 
she sought medical care. The time of exposure to ED arrival 
was approximately 20 minutes.
Initial presentation revealed a patient in significant 
distress, crying out in pain. Vital signs were notable for mild 
tachycardia and otherwise within normal limits. Pertinent 
exam findings included labial and vaginal erythema and 
extreme sensitivity. The pepper spray canister was analyzed 
and found to contain capsaicin without other significant 
irritant or corrosive additives.
Analgesia was attempted with four milligrams (mg) of 
intravenous (IV) morphine, which had no observed effect over 
a 15-minute period. Management was then directed towards 
neutralizing and displacing the capsaicin from the mucosa. A 
medium-sized, disposable plastic speculum was obtained and 
lubricated with 2% lidocaine jelly while two tampons were 
presoaked in cold, pasteurized 2% skim milk. After patient 
consent, a standard speculum exam was performed, which was 
notable for vaginal mucosal erythema without ulcerations or 
bleeding. The saturated tampons were then placed in-line 
within the vaginal canal and the speculum was removed 
leaving the tampons in place with the strings externalized to 
permit easy removal. An icepack and milk-soaked towel were 
then placed over the groin.
The patient rapidly achieved significant pain relief 
within 5-7 minutes with a reported reduction in her pain 
scale from 10/10 to 3/10.  After an approximately 
15-minute dwell time the tampons were removed; the 
patient was observed for a brief period and then discharged 
to home in stable condition.
 
DISCUSSION
Pain management in the ED commonly involves IV and 
oral medications. This case, however, highlights the fact that 
topical irritants can be more effectively managed via direct 
anesthesia and displacement of the offending compound. 
Topical anesthetics such as lidocaine alleviate pain through 
inhibition of sensory neurons via sodium channel blockade. 
Viscous preparations more effectively adhere to the involved 
tissue, but will be absorbed by mucosal tissue so it is 
important to keep in mind the toxic dose based on patient 
weight. Furthermore, lidocaine uptake will be increased in 
abraded tissue and should be kept in mind. Toxicity can occur 
at doses over 5-7 mg per kilogram and may result in cardiac 
arrhythmias or seizures.
Strategies to directly displace an irritant must take into 
account the nature of the compound. Hydrophilic substances 
such as water will have little to no efficacy in displacing 
hydrophobic molecules such as capsaicin from sensory 
receptors. Milk, on the other hand, is readily available in the 
hospital setting and contains the hydrophobic protein casein, 
which effectively displaces capsaicin, quickly relieving pain. 
Ten percent glucose solutions, also readily available in the 
ED, have additionally been shown to decrease the pain 
associated with capsaicin exposure; however, this has only 
been studied in the oral cavity and may not be generalizable to 
other areas of the body.8 
As with all patient chemical exposures, measures should 
be taken to limit healthcare worker contamination. 
Appropriate personal protective equipment such as gloves, 
gowns, and face shields should be used.
CONCLUSION
While capsaicin exposure is not uncommon and typically 
involves the face, this case illustrates a novel approach to 
managing an unusual case of vaginal mucosal involvement 
and presents effective strategies for pain management using 
readily available therapies. As emergency physicians we must 
be prepared to quickly adapt to challenging cases and think 
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outside the box. The ideal or most accessible treatment may 
not always be in your department’s medical cabinet.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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